Skip to main content
. Author manuscript; available in PMC: 2017 Jan 2.
Published in final edited form as: J Neurosurg. 2016 Apr 1;126(1):319–329. doi: 10.3171/2015.12.JNS152443

Table 1.

Patient and tumor characteristics of 289 patients with MPNST

N (%) of column total Overall Sporadic NF1-associated RT-associated P Valuea (P Value)b

289(100) 115(39.8) 148(51.2) 26(8.9)
Median age, years (range) 37(1–81) 43(5–81) 33(1–75) 52(20–77) <0.001 (<0.001)
Median tumor size, cm (range) 8.0(1.0–35.0) 6.0(1.0–32.0) 10(2.5–35.0) 6.0(1.5–15.0) <0.001 (<0.001)
Sex
  Female 134(46.4) 52(45.2) 68(45.9) 14(53.8) 0.720 (0.906)
  Male 155(53.6) 63(54.8) 80(54.1) 12(46.2)
Disease at primary diagnosis
  Localized 274(94.8) 105(91.3) 143(96.6) 26(100.0) 0.071 (0.065)
  Metastatic 15(5.2) 10(8.7) 5(3.4) 0(0.0)
Location
  Head/neck 43(14.9) 23(20.0) 13(8.8) 7(26.9) 0.008c (0.211)
    Cervical nerve root 15(5.2) 4(3.5) 5(3.4) 6(23.0)
    Cranial nerve 13(4.5) 8(6.9) 4(2.7) 1(3.8)
    Other nerve 9(3.1) 8(6.9) 1(0.7) 0(0.0)
    Nerve unknown 6(2.1) 3(2.6) 3(2.0) 0(0.0)
  Trunk 157(54.3) 54(47.0) 85(57.4) 18(69.2)
    Brachial plexus trunks/divisions 21(7.3) 5(4.3) 9(6.1) 9(34.6)
    Brachial plexus cords 9(3.1) 4(3.5) 2(1.3) 3(11.5)
    Lumbosacral nerve root 37(12.8) 19(16.5) 18(12.2) 0(0.0)
    Thoracic nerve root 17(5.9) 3(2.6) 12(8.1) 2(7.6)
    Sciatic nerve 12(4.2) 1(0.8) 10(6.8) 1(3.8)
    Phrenic 4(1.4) 1(0.8) 3(2.0) 0(0.0)
    Obturator 4(1.4) 0(0.0) 4(2.7) 0(0.0)
    Femoral 6(2.7) 2(1.7) 3(2.0) 1(5.9)
    Other nerve 25(8.7) 7(6.1) 16(10.8) 2(11.8)
    Nerve unknown 20(6.9) 12(10.4) 8(5.4) 0(0.0)
  Upper extremity 26(8.9) 13(11.3) 12(8.1) 1(3.8)
     Radial nerve 4(1.4) 2(1.7) 2(1.3) 0(0.0)
     Median nerve 7(2.4) 3(2.6) 3(2.0) 1(3.8)
     Ulnar nerve 7(2.4) 3(2.6) 4(2.7) 0(0.0)
     Other nerve 4(1.4) 3(2.6) 1(0.6) 0(0.0)
     Nerve unknown 4(1.4) 2(1.7) 2(1.3) 0(0.0)
  Lower extremity 63(21.8) 25(21.7) 38(25.7) 0(0.0)
     Sciatic nerve 25(8.7) 6(5.2) 19(12.8) 0(0.0)
     Femoral nerve 7(2.4) 3(2.6) 4(1.4) 0(0.0)
     Obturator nerve 2(0.7) 0(0.0) 2(1.3) 0(0.0)
     Tibial nerve 9(3.1) 5(4.3) 4(2.7) 0(0.0)
     Other nerve 10(3.5) 3(2.6) 6(4.1) 0(0.0)
     Nerve unknown 10(3.5) 8(6.9) 2(1.3) 0(0.0)
Depth d
   Deep 272(94.1) 104(90.4) 143(96.6) 25(96.2) 0.096 (0.037)
   Superficial 17(5.9) 11(9.6) 5(3.4) 1(3.8)
Histologic subclassification
   MPNST, not further classified 258(89.3) 94(81.7) 140(94.6) 24(92.3) 0.001 (<0.001)
   Epithelioid 20(6.9) 17(14.8) 2(1.4) 1(3.8)
   Triton tumor 11(3.8) 4(3.5) 6(4.1) 1(3.8)
Grade
   Low-intermediate 12(4.2) 6(5.2) 5(3.4) 1(3.8) 0.791 (0.480)
   High (or not evaluated) 277(95.8) 109(94.8) 143(96.6) 25(96.2)

Percentages may not add to 100 due to rounding. Bold indicates statistical significance of p < 0.05

a

Three group comparison between sporadic, NF1-associated, and RT-associated characteristics

b

Two group comparison between sporadic and NF1-associated characteristics

c

Comparisons between four major anatomical locations (head/neck, trunk, upper extremity, lower extremity)

d

Tumors with extension through or seated below the superficial fascia were considered deep.